X-108680694-C-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_033380.3(COL4A5):c.3958C>T(p.Pro1320Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,207,663 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 40 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033380.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.3958C>T | p.Pro1320Ser | missense_variant | Exon 45 of 53 | 1 | NM_033380.3 | ENSP00000331902.7 | ||
COL4A5 | ENST00000361603.7 | c.3940C>T | p.Pro1314Ser | missense_variant | Exon 43 of 51 | 2 | ENSP00000354505.2 | |||
COL4A5 | ENST00000489230.1 | n.361C>T | non_coding_transcript_exon_variant | Exon 4 of 8 | 5 | |||||
COL4A5 | ENST00000510690.2 | n.452C>T | non_coding_transcript_exon_variant | Exon 3 of 11 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000153 AC: 17AN: 110981Hom.: 0 Cov.: 22 AF XY: 0.0000903 AC XY: 3AN XY: 33205
GnomAD3 exomes AF: 0.000323 AC: 59AN: 182928Hom.: 0 AF XY: 0.000178 AC XY: 12AN XY: 67582
GnomAD4 exome AF: 0.000127 AC: 139AN: 1096632Hom.: 0 Cov.: 30 AF XY: 0.000102 AC XY: 37AN XY: 362204
GnomAD4 genome AF: 0.000153 AC: 17AN: 111031Hom.: 0 Cov.: 22 AF XY: 0.0000902 AC XY: 3AN XY: 33265
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 06, 2017 | - - |
X-linked Alport syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Precision Medicine Center, Zhengzhou University | - | PM1:Located in a mutational hot spot PP3:Multiple lines of computational evidence support a deleterious effect on the gene or gene product - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 28, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at